Evidence from this study contributes to the nursing science and has implications to nursing practice. Stress among nursing students should be monitored and effectively managed to prevent deleterious effects on their health. Nursing interventions focusing on coping skill training could be developed and delivered. Future research may examine the effectiveness of the interventions and/or to further explore variables associated with psychological distress in nursing students.

Background Depressive symptoms are globally recognized as a significant mental health problem in patients with chronic disease, particularly those with systemic lupus erythematosus (SLE). The purpose of this study was to estimate the prevalence and examine biopsychosocial factors of depressive symptoms among patients with SLE. Methods This cross-sectional study was conducted among 185 participants diagnosed with SLE and received treatment for at least 3 months, aged 18–59 years attending the outpatient clinic of a university hospital, Bangkok, Thailand. Depressive symptoms were measured by the Thai version of the Patient Health Questionnaire-9. We assessed Demographic data, the Systemic Lupus Erythematosus Activity Index, the Systemic Lupus International Collaborating Clinics Damage Index, Numeric Rating Scale, Fatigue Severity Scale, Body Image Scale, and the ENRICHD Social Support Instrument. Data were collected from March to May 2021. Multivariable logistic regression was used to analyze the data. Results The proportion of the participants with depressive symptoms was 43.2%, which 8.1% of those patients presented moderate to severe depressive symptoms. In a multivariable logistic regression model, SLE patients with depressive symptoms were more likely to be severe pain (aOR = 12.11, 95% CI: 1.35, 108.46), fatigue (aOR = 2.36, 95%CI: 1.08, 5.14), taking prednisolone ≥15 mg daily (aOR = 5.75, 95%CI: 1.76, 18.80), low satisfied of body image (aOR = 12.49, 95%CI: 2.23, 69.80), and low social support (aOR = 17.96, 95% CI: 1.86, 173.77). Disease flare, organ damage, and family income sufficiency did not significantly increase the risk of depressive symptoms in patients with SLE. Conclusions The findings highlight depressive symptoms in patients with SLE. Therefore, the health professional should be concerned about the perception of body image, level of social support, fatigue, and pain while treating patients with SLE. Public health screening programs to identify depressive symptoms in patients with SLE are needed. In addition, a high dose of prednisolone should be considered if required, along with monitoring.

This cross-sectional descriptive study aimed to examine factors affecting the psychological well-being of female and male Thai students, and to compare gender differences in a psychological well-being promotion model. Participants were 624 students from three secondary schools in Bangkok and Nakhon Pathom provinces, Thailand. Data were collected in 2018 through self-administered questionnaires, and analyzed using descriptive statistics and structural equation modeling. Findings indicated that all factors from the psychological well-being promotion model influenced psychological well-being among female and male students. Resilience and mindfulness were the strongest predictors affecting psychological well-being in both female and male students. Furthermore, there were not any gender differences concerning predictors and statistical parameters of psychological well-being among Thai secondary school students. Nurse educators or healthcare providers may offer interventions to enhance students’ well-being by strengthening resilience, mindfulness, self-efficacy, and social support. The same interventions, considering their preferences, may be provided to both male and female students. Future research should evaluate the effectiveness of the interventions using rigorous research methodology.

Background Depressive symptoms are globally recognized as a significant mental health problem in patients with chronic disease, particularly those with systemic lupus erythematosus (SLE). The purpose of this study was to estimate the prevalence and examine biopsychosocial factors of depressive symptoms among patients with SLE. Methods This cross-sectional study was conducted among 185 participants diagnosed with SLE and received treatment for at least three months, aged 18-59 years attending the outpatient clinic of a university hospital, Bangkok, Thailand. Depressive symptoms were measured by the Thai version of the Patient Health Questionnaire-9 (PHQ-9). We assessed Demographic data, the Systemic Lupus Erythematosus Activity Index (SLEDAI), the Systemic Lupus International Collaborating Clinics Damage Index (SLICC Damage Index), Numeric Rating Scale (NRS), Fatigue Severity Scale (FSS), Body Image Scale (BIS), and the ENRICHD Social Support Instrument (ESSI). Data were collected from March to May 2021. Multivariable logistic regression was used to analyze the data. Result The proportion of the participants with depressive symptoms was 43.2%, while 8.1% of those patients faced moderate to severe depressive symptoms and could be diagnosed with depression. SLE patients with depressive symptoms were more likely to be severe pain (aOR = 12.11, 95%CI = 1.35-108.46), fatigue (aOR = 2.36, 95%CI = 1.08-5.14), taking prednisolone ≥15 mg daily (aOR = 5.75, 95%CI = 1.76-18.80), low satisfied of body image (aOR = 12.49, 95%CI = 2.23-69.80), and low social support (aOR = 17.96, 95% CI = 1.86-173.77). Disease flare, organ damage, and family income sufficiency could not predict the risk of depressive symptoms in patients with SLE (p ≤ .05). Conclusion The findings highlight depressive symptoms in patients with SLE. Therefore, the health professional should be concerned about the perception of body image, level of social support, fatigue, and pain while treating patients with SLE. Public health screening programs to identify depressive symptoms in patients with SLE are needed. In addition, a high dose of prednisolone should be considered if required, along with monitoring.